ATB — Antibiotice SA Cashflow Statement
0.000.00%
Last trade - 00:00- RON1.66bn
- RON1.90bn
- RON675.01m
- 55
- 32
- 17
- 22
Annual cashflow statement for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -140 | -142 | -163 | 135 | 98.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 94.1 | 44.4 | 106 | 122 | 95.1 |
| Capital Expenditures | -48 | -29.1 | -39.9 | -98 | -116 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -48 | -29.1 | -39.9 | -98 | -116 |
| Financing Cash Flow Items | 0 | — | — | -4.09 | -4.61 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.86 | -8.42 | -12.6 | -24.2 | 21.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 42.8 | 6.87 | 52.8 | 0.08 | 0.873 |